S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2020

RA Capital Management

Period: Q4 2020 Β· Filed: 2021-02-16
View on SEC EDGAR β†—
AUM
$7.15B
Total portfolio value
Positions
82
Reported securities
Top Holding
ASND
13.7% $978.2M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-02-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A S$978.2M13.67%$166.78$274.50+64.6%
13.7%
TGTXTG THERAPEUTICS INC$451.8M6.32%$52.02$53.31+2.5%
6.3%
NVAXNOVAVAX INC$422.5M5.91%$111.51$9.74-91.3%
5.9%
NKTXNKARTA INC$344.6M4.82%$61.47$3.22-94.8%
4.8%
FMTXFORMA THERAPEUTICS HLDGS INC$314.5M4.40%β€”β€”
4.4%
ARVNARVINAS INC$311.9M4.36%$84.93$8.39-90.1%
4.4%
CCXICHEMOCENTRYX INC$295.8M4.13%β€”$19.10
4.1%
AVIRATEA PHARMACEUTICALS INC$224.3M3.14%$41.78$4.98-88.1%
3.1%
ITOSITEOS THERAPEUTICS INC$149.4M2.09%β€”β€”
2.1%
KNTEKINNATE BIOPHARMA INC$142.9M2.00%β€”β€”
2.0%
AXSMAXSOME THERAPEUTICS INC$134.9M1.89%$81.47$244.31+199.9%
1.9%
KROSKEROS THERAPEUTICS INC$132.3M1.85%$70.54$11.26-84.0%
1.9%
PHATPHATHOM PHARMACEUTICALS INC$127.1M1.78%$33.22$11.20-66.3%
1.8%
RYTMRHYTHM PHARMACEUTICALS INC$124.2M1.74%$29.73$114.17+284.0%
1.7%
TVTXTRAVERE THERAPEUTICS INC$124.2M1.74%$27.25$56.92+108.9%
1.7%
IMGNIMMUNOGEN INC$118.8M1.66%β€”β€”
1.7%
RCKTROCKET PHARMACEUTICALS INC COM$117.1M1.64%$54.84$3.84-93.0%
1.6%
ETNB89BIO INC$115.4M1.61%β€”β€”
1.6%
ZGNXZOGENIX INC$106.9M1.49%β€”β€”
1.5%
PMVPPMV PHARMACEUTICALS INC$105.2M1.47%$61.51$1.22-98.0%
1.5%
OLMAOLEMA PHARMACEUTICALS INC$103.4M1.45%$48.08$12.64-73.7%
1.4%
ADVMADVERUM BIOTECHNOLOGIES INC$103.0M1.44%β€”β€”
1.4%
MGNXMACROGENICS INC$100.0M1.40%$22.86$4.71-79.4%
1.4%
PCVXVAXCYTE INC$98.6M1.38%$26.57$58.39+119.8%
1.4%
IGMSIGM BIOSCIENCES INC$86.8M1.21%β€”β€”
1.2%
BDTXBLACK DIAMOND THERAPEUTICS INC$83.0M1.16%$32.05$2.01-93.7%
1.2%
SPRYSILVERBACK THERAPEUTICS INC$80.7M1.13%$46.34$8.56-81.5%
1.1%
TRILLIUM THERAPEUTICS INC$77.8M1.09%β€”β€”
1.1%
SLDBSOLID BIOSCIENCES INC$75.6M1.06%$113.70$10.84-90.5%
1.1%
KALAKALA PHARMACEUTICALS INC$73.7M1.03%$16950.00$1.68-100.0%
1.0%

Quarter-on-Quarter Activity

Q4 2020 vs. Q3 2020

New Positions (8)

TickerIssuerNotionalSince Filing
AVIRATEA PHARMACEUTICALS INC$224.3M-88.1%
KNTEKINNATE BIOPHARMA INC$142.9M
TVTXTRAVERE THERAPEUTICS INC$124.2M+108.9%
RCKTROCKET PHARMACEUTICALS INC COM$117.1M-93.0%
OLMAOLEMA PHARMACEUTICALS INC$103.4M-73.7%
SPRYSILVERBACK THERAPEUTICS INC$80.7M-81.5%
FPRXFIVE PRIME THERAPEUTICS INC$72.9M
CRISCURIS INC$63.1M

Exited Positions (8)

TickerIssuerNotional
MCRBSERES THERAPEUTICS INC$134.5M
EIDXEIDOS THERAPEUTICS INC$109.3M
RTRXRETROPHIN INC$85.6M
RLMDRELMADA THERAPEUTICS INC$29.4M
PRVLPREVAIL THERAPEUTICS INC$19.5M
FSDCFS DEV CORP$11.2M
VSTMXXXXVERASTEM INC$9.8M
ARYBUARYA SCIENCES ACQUISITION CORP$7.7M

Increased (4)

TickerIssuerNotionalShares Ξ”Since Filing
NVAXNOVAVAX INC$292.6M+216.1%-91.3%
IMGNIMMUNOGEN INC$93.5M+161.6%
SLDBSOLID BIOSCIENCES INC$66.3M+118.3%-90.5%
ADVMADVERUM BIOTECHNOLOGIES INC$6.1M+1.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-76.9M-77.9%
CRNXCRINETICS PHARMACEUTICALS INC$-28.5M-75.8%
VXRTVAXART INC$-56.2M-74.6%
OCULOCULAR THERAPEUTIX INC$-5.2M-72.5%
ALECALECTOR INC$-13.7M-55.3%
PCVXVAXCYTE INC$-162.3M-29.8%+119.8%
RYTMRHYTHM PHARMACEUTICALS INC$12.8M-18.7%+284.0%
AXSMAXSOME THERAPEUTICS INC$-10.1M-18.7%+199.9%
← Back to Hedge Funds